About IOTA Pharma
IOTA Pharma was a Healthcare company based in Cambridge (United States) founded in 2007. It offers fragment-based drug discovery products and services. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Discovery and Research Services. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
IOTA Pharma, backed by 905589.5157000001 from European Union, focuses on providing healthcare solutions, producing pharmaceutical products, drug discovery, and research services. Offers fragment-based drug discovery products and services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Cambridge, United States
- SectorsHealthcare
- Website iotapharma.com
- Latest Funding Round$402.67K (USD), Grant
Jan 2017
- Investors
Funding Insights of IOTA Pharma
- Total Rounds 3
- Last Round Grant — $402,668
- First Round $502,921
(Jan 2014)
- Investors Count 1
All 3 funding rounds of IOTA Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $402,668 | Grant | – | – | |
| Mar 2014 | $502,921 | Grant | – | – | |
| Jan 2014 | $502,921 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in IOTA Pharma
IOTA Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for IOTA Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IOTA Pharma
3 dated milestones of IOTA Pharma across 10 years, from founding to its latest funding, stage changes and deals.
- Founded IOTA Pharma is founded.
- Funding First funding round of $503K.
- Funding Latest funding round, Grant, of $403K.
Competitors of IOTA Pharma
IOTA Pharma has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of IOTA Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as IOTA Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Iota Pharma
Complete news archive for IOTA Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IOTA Pharma
IOTA Pharma was founded in 2007 and raised its 1st funding round 7 years after it was founded.
IOTA Pharma is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
IOTA Pharma, backed by 905589.5157000001 from European Union, focuses on providing healthcare solutions, producing pharmaceutical products, drug discovery, and research services. Offers fragment-based drug discovery products and services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
IOTA Pharma's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
IOTA Pharma has 1 investor. Key investors include European Union.